[go: up one dir, main page]

NO20063809L - Belagte minitabletter av venlaflaxin hydroklorid med forlenget virkning - Google Patents

Belagte minitabletter av venlaflaxin hydroklorid med forlenget virkning

Info

Publication number
NO20063809L
NO20063809L NO20063809A NO20063809A NO20063809L NO 20063809 L NO20063809 L NO 20063809L NO 20063809 A NO20063809 A NO 20063809A NO 20063809 A NO20063809 A NO 20063809A NO 20063809 L NO20063809 L NO 20063809L
Authority
NO
Norway
Prior art keywords
hydrochloride
venlaflaxin
mini tablets
extended action
coated mini
Prior art date
Application number
NO20063809A
Other languages
English (en)
Inventor
Sampad Bhattacharya
Rajesh Kshirsagar
Mayank Joshi
Sandeep Pandita
Original Assignee
Alembic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alembic Ltd filed Critical Alembic Ltd
Publication of NO20063809L publication Critical patent/NO20063809L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Foreliggende oppfinnelse angår en farmasøytisk formulering med forlenget fiigjøring som taes en gang per dag, og omfatter venlafaxin hydroklorid og farmasøytisk akseptable eksipienter. Mer spesifikt angår foreliggende oppfinnelse en sammensetning med forlenget fiigjøring i form av minitabletter som er inkorporert i harde gelatin kapsler.
NO20063809A 2004-02-04 2006-08-25 Belagte minitabletter av venlaflaxin hydroklorid med forlenget virkning NO20063809L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN117MU2004 2004-02-04
IN980MU2004 2004-09-13
PCT/IN2004/000340 WO2005074895A1 (en) 2004-02-04 2004-10-27 Extended release coated microtablets of venlafaxine hydrochloride

Publications (1)

Publication Number Publication Date
NO20063809L true NO20063809L (no) 2006-08-25

Family

ID=34809925

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063809A NO20063809L (no) 2004-02-04 2006-08-25 Belagte minitabletter av venlaflaxin hydroklorid med forlenget virkning

Country Status (22)

Country Link
US (1) US7807195B2 (no)
EP (1) EP1711169B1 (no)
JP (1) JP2007520547A (no)
AT (1) ATE361743T1 (no)
AU (1) AU2004315136B2 (no)
BR (1) BRPI0418283A (no)
CA (1) CA2555295C (no)
CY (1) CY1106741T1 (no)
DE (1) DE602004006443T2 (no)
DK (1) DK1711169T3 (no)
ES (1) ES2287813T3 (no)
HR (1) HRP20070353T3 (no)
IL (1) IL177243A0 (no)
MX (1) MXPA06008854A (no)
NO (1) NO20063809L (no)
NZ (1) NZ548504A (no)
PL (1) PL1711169T3 (no)
PT (1) PT1711169E (no)
RU (1) RU2340331C2 (no)
SI (1) SI1711169T1 (no)
UA (1) UA82597C2 (no)
WO (1) WO2005074895A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146462A (en) 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
EP1572160A2 (en) * 2002-11-28 2005-09-14 Themis Laboratories Private Limited Process for manufacturing sustained release microbeads containing venlafaxine hci
WO2006136927A1 (en) * 2005-06-22 2006-12-28 Glenmark Pharmaceuticals Limited Extended release formulations comprising venlafaxine
EP1906935A4 (en) * 2005-07-28 2010-10-20 Reddys Lab Ltd Dr VENLAFAXIN COMPOSITIONS WITH EXTENDED RELEASE
WO2007102169A1 (en) * 2006-03-08 2007-09-13 Jubilant Organosys Limited Extended release pharmaceutical formulation of venlafaxine and method of manufacturing the same
WO2007112574A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Extended release composition of venlafaxine
EP2010162A4 (en) * 2006-04-03 2013-01-09 Isa Odidi COMPOSITION FOR DISPOSING A MEDICINAL PRODUCT
WO2007129329A2 (en) * 2006-05-08 2007-11-15 Jubilant Organosys Limited Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
US20100179110A1 (en) * 2006-12-20 2010-07-15 Mostafa Akbarieh Composition Containing a Bisphosphonic Acid in Combination with Vitamin D
EP2114455A4 (en) * 2006-12-20 2010-03-17 Mylan Pharmaceuticals Ulc PHARMACEUTICAL COMPOSITION USING A HOT-MELT GRANULATED AGENT
TWI391150B (zh) * 2008-01-22 2013-04-01 Taiwan Biotech Co Ltd 腸溶性長效塗覆芯與藥物劑型及其製造方法
CN101756934A (zh) * 2008-12-10 2010-06-30 上海复星普适医药科技有限公司 文拉法辛缓释制剂的制备方法
KR101787481B1 (ko) 2010-10-21 2017-10-18 롯데정밀화학 주식회사 장용성 경질 캡슐용 조성물 및 상기 조성물을 사용하여 제조된 장용성 경질 캡슐
CA2826180C (en) 2011-01-31 2020-09-01 Serotech, Llc Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder
DK3395342T3 (da) 2015-12-25 2020-10-12 Fujifilm Toyama Chemical Co Ltd Tablet omfattende 1-(3-(2-(1-benzothiophen-5-YL)ethoxy)propyl)azetidin-3-ol eller salt deraf

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153677A (en) * 1978-05-18 1979-05-08 Sterling Drug Inc. Controlled-release composition
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6274171B1 (en) * 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
PE57198A1 (es) 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
UA77145C2 (en) * 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
KR100602047B1 (ko) * 1998-05-15 2006-07-19 워너-램버트 캄파니 엘엘씨 감마-아미노부티르산 유도체의 안정화된 제약 제제 및그의 제조 방법
KR100748913B1 (ko) 1999-11-22 2007-08-13 알자 코포레이션 제 1 및 제 2 를 함유하는 삼투성 투약 형태
US6346269B1 (en) * 2000-05-08 2002-02-12 Standard Chem. & Pharm. Co., Ltd. Method for preparing an oral formulation containing acid-sensitive drugs and oral formulation made thereby
US6350471B1 (en) * 2000-05-31 2002-02-26 Pharma Pass Llc Tablet comprising a delayed release coating
AU2002248792B2 (en) * 2001-04-18 2006-09-21 Nostrum Pharmaceuticals Inc. A novel coating for a sustained release pharmaceutical composition
US20030091634A1 (en) * 2001-09-14 2003-05-15 Pawan Seth Delayed release tablet of venlafaxin
BR0215262A (pt) 2001-12-20 2004-12-28 Pharmacia Corp Formas de dosagem com liberação sustentada de ordem zero e processo para a fabricação das mesmas
WO2003055475A1 (en) * 2002-01-03 2003-07-10 Lek Pharmaceutical And Chemical Company D.D. Controlled release pharmaceutical formulation containing venlafaxine
AU2003226751A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Low water-soluble venlafaxine salts
AU2003226748A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Compositions of venlafaxine base
IL149055A0 (en) * 2002-04-09 2002-11-10 Karma Pharm Ltd Extended release composition comprising as active compound venlafaxine hydrochloride
US20060257482A1 (en) * 2002-06-07 2006-11-16 Patrik Kumar Modified release, multiple unit drug delivery systems
US8216609B2 (en) * 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US7058999B2 (en) * 2002-10-24 2006-06-13 Paramount Bed Co., Ltd. Electric bed and control apparatus and control method therefor
EP1558222A2 (en) * 2002-10-25 2005-08-03 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions containing venlafaxine
US6703044B1 (en) * 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
EP1596837A2 (en) * 2003-02-07 2005-11-23 Omega Farma Ehf Sustained release formulations of venlafaxine
EP1502587B1 (en) * 2003-07-30 2006-08-23 Pharmathen S.A. Sustained release formulation for Venlafaxine hydrochloride
US7016014B2 (en) * 2004-02-27 2006-03-21 Asml Netherlands B.V Lithographic apparatus and device manufacturing method

Also Published As

Publication number Publication date
CA2555295A1 (en) 2005-08-18
DE602004006443T2 (de) 2008-01-10
EP1711169B1 (en) 2007-05-09
ATE361743T1 (de) 2007-06-15
DK1711169T3 (da) 2007-09-17
SI1711169T1 (sl) 2007-10-31
KR20070000439A (ko) 2007-01-02
AU2004315136A1 (en) 2005-08-18
CA2555295C (en) 2011-01-18
CY1106741T1 (el) 2012-05-23
IL177243A0 (en) 2006-12-10
HRP20070353T3 (en) 2008-01-31
EP1711169A1 (en) 2006-10-18
BRPI0418283A (pt) 2007-05-02
RU2340331C2 (ru) 2008-12-10
PT1711169E (pt) 2007-07-23
AU2004315136B2 (en) 2010-06-17
PL1711169T3 (pl) 2007-10-31
UA82597C2 (uk) 2008-04-25
US20050169985A1 (en) 2005-08-04
NZ548504A (en) 2009-03-31
DE602004006443D1 (de) 2007-06-21
HK1091137A1 (en) 2007-01-12
RU2006129034A (ru) 2008-03-10
WO2005074895A1 (en) 2005-08-18
MXPA06008854A (es) 2007-01-23
US7807195B2 (en) 2010-10-05
JP2007520547A (ja) 2007-07-26
ES2287813T3 (es) 2007-12-16

Similar Documents

Publication Publication Date Title
NO20063809L (no) Belagte minitabletter av venlaflaxin hydroklorid med forlenget virkning
AR116052A2 (es) Forma cristalina de clorhidrato de (-)-(1r,2r)-3-(3-dimetilamino-1-etil-2-metilpropil)-fenol
PE20050175A1 (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad
NO20100250L (no) Farmasoytisk preparat som innbefatter en S1P reseptoragonist og en sukkeralkohol, og framgangsmate til fremstilling derav
AR049083A1 (es) Proceso para la preparacion de una forma de dosificacion solida a prueba de abuso
ATE454138T1 (de) Tablette mit modifizierter freisetzung von bupropion hydrochlorid
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
NO20081038L (no) Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering
ECSP077999A (es) Formulaciones de una sal de bupropion de liberación modificada
DK1792927T3 (da) Ny blokcopolymer, micelletilberedning og anticancermiddel indeholdende samme som aktiv ingrediens
ECSP045102A (es) Formulación farmacéutica que contiene 3-(3-dimetilamino-1-etil-2-metil-propil)fenol y proporciona una liberación retardada del ingrediente activo
EA200970267A1 (ru) ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ВКЛЮЧАЮЩАЯ МНОЖЕСТВО МИНИ-ТАБЛЕТОК, СОДЕРЖАЩИХ ИНГИБИТОР ФАКТОРА Xa
MX2009001711A (es) Formulaciones de liberacion sostenida de topiramato.
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
ECSP045409A (es) Composiciones y metodos para dosificar liposomas de ciertos tamaños a fin de tratar o prevenir enfermedades.
MY136136A (en) Pharmaceutical compositions containing terbinafin and use thereof
CY1106693T1 (el) Πελετες οι οποιες περιεχουν υδροχλωρικη βενλαφαξινη
NO341573B1 (no) Faste formuleringer av ospemifen og fremgangsmåte for fremstilling av ospemifen
UY25234A1 (es) Formulación de liberación prolongada de venlafaxina
ES2305567T3 (es) Formulaciones de tramadol de liberacion sostenida con una eficacia de 24 horas.
PE20080313A1 (es) Formulaciones de liberacion pulsada de fenilefrina y composiciones farmaceuticas
CO6351711A2 (es) Combinacion de dosis fija en la forma de una tableta de dos copas o de una sola capa de alisquireno y amlodipina
AR039162A1 (es) Formulaciones de venlafaxina de liberacion extendida
UY38028A (es) Combinación farmacéutica en la forma de comprimidos en bicapa que comprende ketorolaco trometamina y su uso para el tratamiento del dolor
NO20051261L (no) Morfin-6-glukuronidsalt

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application